Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Finasteride effectively treats male hair loss, increasing length and thickness.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Animal models are crucial for learning about hair loss and finding treatments.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Different hair fiber development might explain why hair loss severity varies in patients with a specific genetic mutation, and treatments that thicken hair could help.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Oxidative stress contributes to hair graying and loss as we age.

One minoxidil-sensitive potassium channel exists in human hair follicles.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Gray hair can potentially be reversed, leading to new treatments.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Treatments for melanin disorders exist, but more effective options needed.